Search Results

There are 193991 results for: content related to: Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists

  1. You have free access to this content
    Regression of Cardiac Valvulopathy Related to Ergot-Derived Dopamine Agonists

    Cardiovascular Therapeutics

    Volume 29, Issue 6, December 2011, Pages: 404–410, Renzo Zanettini, Angelo Antonini, Gemma Gatto, Rosa Gentile, Silvana Tesei and Gianni Pezzoli

    Version of Record online : 11 JUN 2010, DOI: 10.1111/j.1755-5922.2010.00169.x

  2. You have free access to this content
    Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice

    Movement Disorders

    Volume 23, Issue 16, 15 December 2008, Pages: 2267–2302, Claudia Trenkwalder, Wayne A. Hening, Pasquale Montagna, Wolfgang H. Oertel, Richard P. Allen, Arthur S. Walters, Joao Costa, Karin Stiasny-Kolster and Cristina Sampaio

    Version of Record online : 16 OCT 2008, DOI: 10.1002/mds.22254

  3. Abstracts and Citations

    Headache: The Journal of Head and Face Pain

    Volume 47, Issue 6, June 2007, Pages: 936–944, Stewart J. Tepper, Marcelo Bigal and Frederick R. Taylor

    Version of Record online : 18 JUL 2008, DOI: 10.1111/j.1526-4610.2007.00837.x

  4. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

    Movement Disorders

    Volume 21, Issue 3, March 2006, Pages: 343–353, Wolfgang H. Oertel, Erik Wolters, Cristina Sampaio, Santiago Gimenez-Roldan, Bruno Bergamasco, Max Dujardin, Donald G. Grosset, Guy Arnold, Klaus L. Leenders, Hans-Peter Hundemer, Alberto Lledó, Andrew Wood, Paul Frewer and Johannes Schwarz

    Version of Record online : 6 OCT 2005, DOI: 10.1002/mds.20724

  5. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  6. Table of Contents

    The Brown University Geriatric Psychopharmacology Update

    Volume 11, Issue 4, April 2007, Pages: 1–8,

    Version of Record online : 22 MAR 2007, DOI: 10.1002/gpu.20041

  7. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  8. Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists

    Movement Disorders

    Volume 24, Issue 1, 15 January 2009, Pages: 129–133, Frank Andersohn and Edeltraut Garbe

    Version of Record online : 17 NOV 2008, DOI: 10.1002/mds.22385

  9. Parkinson's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt084

  10. Table of Contents

    The Brown University Psychopharmacology Update

    Volume 18, Issue 4, April 2007, Pages: 1–8,

    Version of Record online : 23 MAR 2007, DOI: 10.1002/pu.20041

  11. You have free access to this content
    High-sensitivity quantitation of cabergoline and pergolide using a triple-quadrupole mass spectrometer with enhanced mass-resolution capabilities

    Journal of Mass Spectrometry

    Volume 38, Issue 7, July 2003, Pages: 743–751, Nicola Hughes, Witold Winnik, Jean-Jacques Dunyach, Ma'an Amad, Maurizio Splendore and Gary Paul

    Version of Record online : 15 JUL 2003, DOI: 10.1002/jms.489

  12. The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists

    Movement Disorders

    Volume 26, Issue 5, April 2011, Pages: 801–806, Vibeke Guldbrand Rasmussen, Karen Østergaard, Erik Dupont and Steen Hvitfeldt Poulsen

    Version of Record online : 24 JAN 2011, DOI: 10.1002/mds.23470

  13. Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study

    Movement Disorders

    Volume 21, Issue 8, August 2006, Pages: 1109–1113, Cecilia Peralta, Elisabeth Wolf, Hannes Alber, Klaus Seppi, Silvana Müller, Sylvia Bösch, Gregor K. Wenning, Otmar Pachinger and Werner Poewe

    Version of Record online : 18 APR 2006, DOI: 10.1002/mds.20887

  14. You have free access to this content
    Heart valve disease associated with treatment with ergot-derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson’s disease

    Journal of Internal Medicine

    Volume 263, Issue 1, January 2008, Pages: 90–98, V. G. Rasmussen, S. H. Poulsen, E. Dupont, K. Østergaard, G. Safikhany and H. Egeblad

    Version of Record online : 23 NOV 2007, DOI: 10.1111/j.1365-2796.2007.01874.x

  15. Poster Session 3

    Movement Disorders

    Volume 21, Issue S15, September 2006, Pages: S517–S613,

    Version of Record online : 20 SEP 2006, DOI: 10.1002/mds.21248

  16. Restless Legs Syndrome and Periodic Limb Movement Disorder

    European Handbook of Neurological Management

    L. Vignatelli, M. Billiard, P. Clarenbach, D. Garcia-Borreguero, D. Kaynak, V. Liesiene, C. Trenkwalder, P. Montagna, Pages: 569–591, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753279.ch43

  17. Pergolide for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    C E Clarke and Julie Speller

    Published Online : 26 APR 1999, DOI: 10.1002/14651858.CD000235

  18. Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations

    Movement Disorders

    Volume 16, Issue 5, September 2001, Pages: 858–866, William Koller, Andrew Lees, Miroslava Doder, Mariese Hely and the Tolcapone/Pergolide Study Group

    Version of Record online : 20 SEP 2001, DOI: 10.1002/mds.1175

  19. Poster session 2: Monday, March 7, Poster numbers 188–383

    Movement Disorders

    Volume 20, Issue S10, February 2005, Pages: S57–S113,

    Version of Record online : 9 FEB 2005, DOI: 10.1002/mds.20423

  20. Pergolide, a potent long-acting dopamine-receptor agonist

    Clinical Pharmacology & Therapeutics

    Volume 27, Issue 5, May 1980, Pages: 642–651, Louis Lemberger, Ross Crabtree and J Thomas Callaghan

    Version of Record online : 11 MAY 1980, DOI: 10.1038/clpt.1980.91